Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

46 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Serum biomarkers in idiopathic pulmonary fibrosis.
van den Blink B, Wijsenbeek MS, Hoogsteden HC. van den Blink B, et al. Pulm Pharmacol Ther. 2010 Dec;23(6):515-20. doi: 10.1016/j.pupt.2010.08.001. Epub 2010 Aug 12. Pulm Pharmacol Ther. 2010. PMID: 20708704 Review.
Protease-activated receptor-2 induces myofibroblast differentiation and tissue factor up-regulation during bleomycin-induced lung injury: potential role in pulmonary fibrosis.
Borensztajn K, Bresser P, van der Loos C, Bot I, van den Blink B, den Bakker MA, Daalhuisen J, Groot AP, Peppelenbosch MP, von der Thüsen JH, Spek CA. Borensztajn K, et al. Among authors: van der loos c, den bakker ma, van den blink b. Am J Pathol. 2010 Dec;177(6):2753-64. doi: 10.2353/ajpath.2010.091107. Epub 2010 Oct 22. Am J Pathol. 2010. PMID: 20971733 Free PMC article.
[High mortality in patients with idiopathic pulmonary fibrosis on Dutch lung transplant waiting list].
ten Klooster L, van Moorsel CH, van Hal PT, van den Blink B, Nossent GD, Verschuuren EA, Kwakkel-van Erp JM, van de Graaf EA, van Kessel DA, Grutters JC. ten Klooster L, et al. Among authors: van de graaf ea, van moorsel ch, van kessel da, van den blink b, van hal pt. Ned Tijdschr Geneeskd. 2012;156(2):A3752. Ned Tijdschr Geneeskd. 2012. PMID: 22236616 Dutch.
Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis.
Dillingh MR, van den Blink B, Moerland M, van Dongen MG, Levi M, Kleinjan A, Wijsenbeek MS, Lupher ML Jr, Harper DM, Getsy JA, Hoogsteden HC, Burggraaf J. Dillingh MR, et al. Among authors: van dongen mg, van den blink b. Pulm Pharmacol Ther. 2013 Dec;26(6):672-6. doi: 10.1016/j.pupt.2013.01.008. Epub 2013 Feb 4. Pulm Pharmacol Ther. 2013. PMID: 23380438 Clinical Trial.
[Idiopathic pulmonary fibrosis: new insights].
Kraan JW, van den Blink B, van den Toorn LM, Bresser P, van Beek FT, Grutters JC, Wijsenbeek MS. Kraan JW, et al. Among authors: van beek ft, van den toorn lm, van den blink b. Ned Tijdschr Geneeskd. 2015;159:A8148. Ned Tijdschr Geneeskd. 2015. PMID: 25654681 Review. Dutch.
Impaired survival of regulatory T cells in pulmonary sarcoidosis.
Broos CE, van Nimwegen M, Kleinjan A, ten Berge B, Muskens F, in 't Veen JC, Annema JT, Lambrecht BN, Hoogsteden HC, Hendriks RW, Kool M, van den Blink B. Broos CE, et al. Among authors: van nimwegen m, van den blink b. Respir Res. 2015 Sep 16;16(1):108. doi: 10.1186/s12931-015-0265-8. Respir Res. 2015. PMID: 26376720 Free PMC article.
Ten-Year Survival in Patients with Idiopathic Pulmonary Fibrosis After Lung Transplantation.
ten Klooster L, Nossent GD, Kwakkel-van Erp JM, van Kessel DA, Oudijk EJ, van de Graaf EA, Luijk B, Hoek RA, van den Blink B, van Hal PT, Verschuuren EA, van der Bij W, van Moorsel CH, Grutters JC. ten Klooster L, et al. Among authors: van de graaf ea, van moorsel ch, van kessel da, van den blink b, van hal pt, van der bij w. Lung. 2015 Dec;193(6):919-26. doi: 10.1007/s00408-015-9794-7. Epub 2015 Sep 24. Lung. 2015. PMID: 26404700
46 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page